MDC — Mediclinic International Income Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedLarge Cap
- £3.69bn
- £6.12bn
- £3.23bn
C2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,876 | 2,932 | 3,083 | 2,995 | 3,233 |
Cost of Revenue | |||||
Gross Profit | 1,097 | 1,105 | 1,123 | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,273 | 3,015 | 3,277 | 2,726 | 2,953 |
Operating Profit | -397 | -83 | -194 | 269 | 280 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -479 | -137 | -275 | 104 | 211 |
Provision for Income Taxes | |||||
Net Income After Taxes | -474 | -130 | -299 | 79 | 170 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -492 | -151 | -320 | 68 | 151 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -492 | -151 | -320 | 68 | 151 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | 0.155 | 0.27 | 0.023 | 0.195 |
Dividends per Share |